Researchers developed a prophylactic phage therapy targeting Salmonella enterica Typhimurium that in mouse models colonized the gut, and produced lytic phages that protected against future infection by the pathogen, improving survival.
Researchers developed a prophylactic phage therapy targeting Salmonella enterica Typhimurium that in mouse models colonized the gut, and produced lytic phages that protected against future infection by the...
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
Researchers developed a prophylactic phage therapy targeting Salmonella enterica Typhimurium that in mouse models colonized the gut, and produced lytic phages that protected against future infection by the pathogen, improving survival.
Open the app view to save this story, compare related coverage, and continue from the same source.